Preparation method of leuprorelin impurity K

Through fragment synthesis and solid-liquid combination reaction, the addition reaction between Dha and piperidine is avoided, the synthesis efficiency and purity of leuprolide impurity K is improved, and the efficiency and cost of low efficiency and high cost in the preparation process in the prior art are solved. Problem, high-purity industrial production has been achieved.

CN119039384APending Publication Date: 2024-11-29SHENZHEN JYMED TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310621454.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-29
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

During the preparation process, the leuprolide impurity K is sensitive to piperidine and other nucleophilic reagents, resulting in the addition reaction to produce a symmetrical configuration of N-piperidinyl-alanine structure, resulting in low synthesis efficiency and high cost. And it is difficult to achieve high purity industrial production.

Method used

Using fragment synthesis method, it is divided into steps 1: synthesize fragment 1 pGlu-His(R1)-Trp(R2)-Dha, and step 2: synthesize fragment 2 H-Tyr(R3)-D-Leu-Leu-Arg(R4) -Pro-NHC2H5, Step 3: Coupling fragments 1 and 2 to obtain fully protected fragment 3, Step 4: Cleavage to obtain leuprolide impurity K, avoid piperidine and other nucleophilic reagents through solid-liquid binding reaction, Protecting group strategies are adopted to improve purity and yield.

Benefits of technology

The synthesis efficiency of leuprolide impurity K is improved, with a purity of more than 78%, a yield of more than 60%, and the purity of HPLC reaches more than 99% after purification, reducing production costs and is suitable for drug quality research and industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119039384A_ABST
    Figure CN119039384A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method of a leuprorelin impurity K. The preparation method comprises the following steps: step 1, synthesizing a fragment 1: pGlu-His (R1)-Trp (R2)-Dha; step 2, synthesizing a fragment 2, namely H-Tyr (R3)-D-Leu-Leu-Arg (R4)-Pro-NHC2H5; step 3, coupling the fragment 1 and the fragment 2 to obtain a fully protected fragment 3: pGlu-His (R1)-Trp (R2)-Dha-Tyr (R3)-D-Leu-Leu-Arg (R4)-Pro-NHC2H5; and step 4, cracking the fragment 3 to obtain the leuprorelin impurity K. The purity of the leuprorelin impurity K crude product prepared through the synthesis method reaches 78% or above, the yield reaches 60% or above, the HPLC purity after purification reaches 99% or above, and the leuprorelin impurity K crude product can be used as an impurity reference substance after structure confirmation and is used for quality research of leuprorelin bulk drugs and preparations.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of polypeptide drug component synthesis, and specifically relates to a method for preparing leuprorelin impurity K. Background Art

[0002] Leuprorelin Leuprorelin is a type of synthetic peptide drug based on the structure of gonadotropin-releasing hormone (GnRH). It is commonly used in China along with goserelin and triptorelin. It is commonly used to treat prostate cancer, breast cancer, endometriosis, uterine fibroids and precocious puberty, or as part of sex-changing hormone therapy.

[0003] Leuprorelin is included in the official pharmacopoeias of many countries / regions, including the United States Pharmacopoeia, the European Pharmacopoeia, the British Pharmacopoeia, the Japanese Pharmacopoeia, and the Chinese Pharmacopoeia. Among them, several impurities with clear structures, from Leuprorelin Impurity A to Leuprorelin Impurity K, are disclosed in the European Pharmacopoeia EP10.0. As far as a drug is concerned, the small amount of impurities contained in it is the most important cause of drug side effects. Therefore, the inspection of its purity is one of the important foundations for ensuring the safety and effectiveness of the drug. The content of the purity inspection varies according to the properties and characteristics of each drug, but basically involves the inspection and research of their respective "related substances". In the quality inspection of leuprorelin, leuprorelin impurities A to leuprorelin impurity K are required as reference substances to check the content of impurities. Therefore, the preparation of high-purity impurities is of great significance to the quality control of leuprorelin.

[0004] The structure of Leuprorelin impurity K is as follows:

[0005]

[0006] pGlu-His-Trp-Dha-Tyr-D-Leu-Leu-Arg-Pro-NHC2H5

[0007] Unlike other impurities, leuprorelin impurity K cannot be directly synthesized through the corresponding racemic amino acids. The Dha in leuprorelin impurity K is sensitive to piperidine and other nucleophiles. After Dha is produced during the preparation process, if piperidine and other nucleophiles are present, an addition reaction will occur to obtain a symmetrical N-piperidyl-alanine structure. Piperidine and nucleophiles are commonly used reagents in polypeptide synthesis, so its preparation is technically difficult. Even if it is prepared, the yield is low and the cost is very high.

[0008] Impurity research is an important part of drug quality research and one of the key factors in drug quality assurance. In order to improve the safety of clinical drug use, it is necessary to conduct detailed research and control on drug process impurities and degradation impurities during storage. For leuprolide, leuprolide impurity K is an impurity included in the official pharmacopoeia, and its quality control of drugs is even more important. Therefore, it is urgent to develop a method for preparing leuprolide impurity K. Summary of the invention

[0009] In order to overcome the above-mentioned problems in the prior art, the present invention provides a method for preparing leuprorelin impurity K, which solves the problem that Dha in leuprorelin impurity K is sensitive to piperidine and other nucleophilic reagents, avoids the addition reaction to obtain a symmetrically configured N-piperidyl-alanine structure, improves the synthesis efficiency of leuprorelin impurity K, improves the yield, reduces the cost, and is conducive to industrial production.

[0010] To this end, the present invention adopts the following technical solutions to solve the above technical problems:

[0011] A method for preparing leuprorelin impurity K, characterized in that it mainly comprises the following steps:

[0012] Step 1, synthesis of fragment 1: pGlu-His(R1)-Trp(R2)-Dha;

[0013] Step 2, synthesis of fragment 2: H-Tyr(R3)-D-Leu-Leu-Arg(R4)-Pro-NHC2H5;

[0014] Step 3, coupling fragments 1 and 2 to obtain fully protected fragment 3: pGlu-His(R1)-Trp(R2)-Dha-Tyr(R3)-D-Leu-Leu-Arg(R4)-Pro-NHC2H5;

[0015] Step 4, fragment 3 is cleaved to obtain leuprorelin impurity K;

[0016] Wherein, R1 is hydrogen or an amino protecting group,

[0017] R2 is hydrogen or an amino protecting group,

[0018] R3 is hydrogen or a hydroxyl protecting group,

[0019] R4 is hydrogen or an amino protecting group.

[0020] In some embodiments, the R1 is selected from Trt, Boc, Mtt.

[0021] In some embodiments, said R2 is selected from Boc.

[0022] In some embodiments, said R3 is selected from OtBu.

[0023] In some embodiments, said R4 is selected from H, pbf, Mts.

[0024] In some embodiments, the preparation method of fragment 1 is:

[0025]

[0026] In some embodiments, the preparation method of pGlu-His(R1)-Trp(R2)-Ser-OMe is as follows: take a resin, load Fmoc-Trp(R2)-OH, sequentially load Fmoc-His(R1)-OH, pGlu-OH, obtain pGlu-His(R1)-Trp(R2)-resin after coupling, obtain pGlu-His(R1)-Trp(R2)-OH after cleavage, then react with H-Ser.OMe.HCl, wash, dry, and concentrate to obtain pGlu-His(R1)-Trp(R2)-Ser-OMe.

[0027] In some embodiments, the resin is CTC resin, Trityl chloride resin.

[0028] In some embodiments, the lysis employs 20% TFE.

[0029] In some embodiments, the preparation method of fragment 2 is as follows: take a resin, load a linker, and then sequentially load Fmoc-Pro-OH, Fmoc-Leu-Arg(R4)-OH, Fmoc-D-Leu-OH, and Fmoc-Tyr(R3)-OH. After the coupling is completed, aminolysis and removal of Fmoc are performed to obtain H-Tyr(R3)-D-Leu-Leu-Arg(R4)-Pro-NHC2H5

[0030] In some embodiments, the resin is an AM resin.

[0031] In some embodiments, the linker is a HMBA linker.

[0032] In some embodiments, the reagent used for the aminolysis is ethylamine:THF=3:7~1:1.

[0033] In some embodiments, the reagent used for removing Fmoc is: 50% diethylamine / DCM.

[0034] The invention provides a method for preparing leuprorelin impurity K, which adopts a fragment synthesis method: synthesizing fragment 1: pGlu-His(R1)-Trp(R2)-Dha; synthesizing fragment 2: H-Tyr(R3)-D-Leu-Leu-Arg(R4)-Pro-NHC2H5; coupling fragments 1 and 2 to obtain leuprorelin impurity K, and adopting a solid-liquid combined reaction mode to avoid using piperidine and other nucleophilic reagents after generating Dha. The invention solves the problem that Dha in leuprorelin impurity K is sensitive to piperidine and other nucleophilic reagents, avoids the occurrence of addition reaction to obtain a symmetrically configured N-piperidyl-alanine structure, improves the synthesis efficiency of leuprorelin impurity K, improves the yield, reduces the cost, and is conducive to industrial production. The purity of the crude product of leuprorelin impurity K prepared by the synthesis method of the present invention reaches more than 78%, the yield reaches more than 60%, and the HPLC purity after purification reaches more than 99%. After structural confirmation, it can be used as an impurity reference substance for quality research of leuprorelin raw materials and preparations. BRIEF DESCRIPTION OF THE DRAWINGS

[0035] Figure 1 : HPLC spectrum of the crude peptide of leuprorelin impurity K of Example 1 of the present invention.

[0036] Figure 2 : HPLC spectrum of the impurity K peptide of leuprorelin in Example 1 of the present invention.

[0037] Figure 3 : MS spectrum of leuprorelin impurity K in Example 1 of the present invention.

[0038] Figure 4 : Schematic diagram of the process of leuprorelin impurity K in Example 1 of the present invention. DETAILED DESCRIPTION

[0039] The specific implementation modes of the present invention are described in detail below in conjunction with the accompanying drawings. The described embodiments are only for illustration and explanation of the present invention and do not constitute the sole limitation of the present invention.

[0040] Example 1: Preparation of Leuprorelin Impurity K

[0041] Preparation of fragment 1: pGlu-His(Trt)-Trp(Boc)-Dha

[0042] Weigh 5.0mmol CTC resin, load Fmoc-Trp(Boc)-OH, and then load Fmoc-His(Trt)-OH and pGlu-OH in sequence. After the coupling is completed, pGlu-His(Trt)-Trp(Boc)-CTC resin is obtained, and the fully protected tripeptide pGlu-His(Trt)-Trp(Boc)-OH is obtained after 20% TFE cleavage;

[0043] 14.20 g of the fully protected tripeptide and 3.62 g of HOPFP (1.3 eq) were dissolved in 200 ml of DCM and stirred to clarify. 4.46 g of EDCI (1.3 eq) was added and reacted for 1 h. 8.09 g of DIEA and 5.56 g of H-Ser.OMe.HCl were added and reacted for 4 hours. The mixture was washed 3 times with 5% potassium bisulfate aqueous solution and 2 times with saturated brine, dried over anhydrous sodium sulfate, and concentrated to obtain an oily substance which was directly used in the next reaction.

[0044] The oily substance from the previous step was dissolved in 100 ml of acetonitrile, and 9.16 g of DSC (2.0 eq) and 4.62 g of DIEA were added. After reacting for 5 hours, the mixture was washed with 5% potassium hydrogen sulfate aqueous solution for 3 times, saturated brine for 2 times, dried over anhydrous sodium sulfate, and concentrated to obtain an oily substance for purification.

[0045] The oily substance from the previous step was dissolved in 150 ml of THF, and the pH was adjusted to above 10 with 1 M NaOH aqueous solution. The temperature was controlled at 25±5° C. and the reaction was stirred for 3 h. The reaction progress was monitored by TLC (DCM / methanol, V / V, 10 / 1).

[0046] TLC showed that the reaction of the raw material was complete, so the reaction was terminated and the pH was adjusted to 7.0. After purification, 2.55 g of pGlu-His(Trt)-Trp(Boc)-Dha was obtained.

[0047] Preparation of fragment 2: H-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-NHC2H5

[0048] Weigh 5.0mmol AM resin, load HMBA linker, and then load Fmoc-Pro-OH, Fmoc-Leu-Arg(Pbf)-OH, Fmoc-D-Leu-OH, and Fmoc-Tyr(OtBu)-OH in sequence. After the coupling, Fmoc-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-HMBA was obtained. linker-AM resin; use ethylamine-THF (1:1, v / v) to deamine the resin for 24 hours, concentrate and precipitate with isopropyl ether, and vacuum dry to obtain the fully protected crude peptide Fmoc-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-NHC2H5; prepare 50% diethylamine / DCM, add the solid to the solution, stir for 30 minutes, and remove Fmoc to obtain H-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-NHC2H5.

[0049] Preparation of Leuprorelin Impurity K

[0050] Dissolve fragment 2 in DMF, dissolve fragment 1 and HOBT in DMF, control the temperature at 0-5°C, slowly add to the reaction bottle, stir and react for 3 hours, monitor the reaction progress by TLC (DCM / methanol, V / V, 10 / 1), and obtain a crude product of leuprorelin impurity K. Take a small amount of the crude product for analysis, and the product is detected by analytical liquid HPLC. Figure 1 As shown, the purity is 78.00% and the yield is 60.2%.

[0051] Take the crude impurity K, dissolve it with purified water, and filter it with a whatman filter membrane after it is completely dissolved. Then purify it using a reverse phase C18 packed column ZB025. 0.1% TFA / acetonitrile is used for equilibrium replacement. After the fractions are detected, they are combined and concentrated by rotary evaporation and freeze-dried to obtain leuprorelin impurity K. The product is tested by analytical liquid phase HPLC. Figure 2 As shown, the purity is 99.12%. The molecular ion peak of the sample detected in the mass spectrometry electrospray ionization source positive ion mode is 1191.74, which is consistent with the theoretical value of the relative molecular mass of leuprorelin impurity K M = 1191.41. The MS spectrum is shown in Figure 3 shown.

[0052] Example 2: Preparation of Leuprorelin Impurity K 2

[0053] Preparation of fragment 1: pGlu-His(Trt)-Trp(Boc)-Dha

[0054] Weigh 5.5mmol CTC resin, load Fmoc-Trp(Boc)-OH, and then load Fmoc-His(Trt)-OH and pGlu-OH in sequence. After coupling, pGlu-His(Trt)-Trp(Boc)-CTC resin is obtained, and 20% TFE is used for cleavage to obtain the fully protected tripeptide pGlu-His(Trt)-Trp(Boc)-OH;

[0055] 14.56 g of the fully protected tripeptide and 3.62 g of HOPFP (1.3 eq) were dissolved in 200 ml of DCM and stirred to clarify. 4.46 g of EDCI (1.3 eq) was added and reacted for 1 h. 8.09 g of DIEA and 5.63 g of H-Ser.OMe.HCl were added and reacted for 4 hours. The mixture was washed 3 times with 5% potassium bisulfate aqueous solution and 2 times with saturated brine, dried over anhydrous sodium sulfate, and concentrated to obtain an oily substance which was directly used in the next reaction.

[0056] The oily substance from the previous step was dissolved in 100 ml of acetonitrile, and 9.16 g of DSC (2.0 eq) and 4.62 g of DIEA were added. After reacting for 5 hours, the mixture was washed with 5% potassium hydrogen sulfate aqueous solution for 3 times, saturated brine for 2 times, dried over anhydrous sodium sulfate, and concentrated to obtain an oily substance for purification.

[0057] The oily substance from the previous step was dissolved in 150 ml of THF, and the pH was adjusted to above 10 with 1 M NaOH aqueous solution. The temperature was controlled at 25±5° C. and the reaction was stirred for 3 h. The reaction progress was monitored by TLC (DCM / methanol, V / V, 10 / 1).

[0058] TLC showed that the reaction of the raw material was complete, so the reaction was terminated and the pH was adjusted to 7.0. After purification, 2.52 g of pGlu-His(Trt)-Trp(Boc)-Dha was obtained.

[0059] Preparation of fragment 2: H-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-NHC2H5

[0060] Weigh 5.0mmol AM resin, load HMBAlinker, and then load Fmoc-Pro-OH, Fmoc-Leu-Arg(Pbf)-OH, Fmoc-D-Leu-OH, and Fmoc-Tyr(OtBu)-OH in sequence. After the coupling, Fmoc-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-HMBA was obtained. linker-AM resin; use ethylamine-THF (3:7, v / v) to deamine the resin for 24 hours, concentrate and precipitate with isopropyl ether, and vacuum dry to obtain the fully protected crude peptide Fmoc-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-NHC2H5; prepare 20% piperidine / DBU, add the solid to the solution, stir for 30 minutes, and remove Fmoc to obtain H-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-NHC2H5.

[0061] Preparation of Leuprorelin Impurity K

[0062] Dissolve fragment 2 in DMF, dissolve fragment 1 and HOBT in DMF, control the temperature at 0-5°C, slowly add to the reaction bottle, stir and react for 3 hours, monitor the reaction progress by TLC (DCM / methanol, V / V, 10 / 1), and obtain the crude product of leuprorelin impurity K. Take a small amount of the crude product for analysis, and the product is tested by analytical liquid HPLC. The HPLC spectrum is consistent with Figure 1 The results are similar, with a purity of 78.05% and a yield of 60.2%.

[0063] Take the crude product of leuprorelin impurity K, dissolve it with purified water, and filter it with a whatman filter membrane after it is completely dissolved. Then purify it using a reverse phase C18 packed column ZB025. 0.1% TFA / acetonitrile is used for equilibrium replacement. After the fractions are detected, they are combined and concentrated by rotary evaporation and freeze-dried to obtain leuprorelin impurity K. The product is tested by analytical liquid HPLC, and the HPLC spectrum is consistent with Figure 2The purity is similar to that shown in Figure 1, and the purity is 99.13%. The molecular ion peak of the sample detected in the positive ion mode of the mass spectrometry electrospray ionization source is 1191.74, which is consistent with the theoretical value of the relative molecular mass of the leuprorelin impurity K, M = 1191.41. The MS spectrum is similar to that of the Figure 3 similar.

[0064] Example 3: Preparation of Leuprorelin Impurity K 2

[0065] Preparation of fragment 1: pGlu-His(Trt)-Trp(Boc)-Dha

[0066] Weigh 5.2mmol CTC resin, load Fmoc-Trp(Boc)-OH, then load Fmoc-His(Trt)-OH and pGlu-OH in sequence. After coupling, pGlu-His(Trt)-Trp(Boc)-CTC resin is obtained, and 20% TFE is used for cleavage to obtain the fully protected tripeptide pGlu-His(Trt)-Trp(Boc)-OH;

[0067] 14.36 g of the fully protected tripeptide and 3.62 g of HOSU (1.3 eq) were dissolved in 200 ml of DCM and stirred to clarify. 4.46 g of DCC (1.3 eq) was added and reacted for 1 h. 8.09 g of DIEA and 5.58 g of H-Ser.OMe.HCl were added and reacted for 4 hours. The solid was filtered to collect the liquid, and then washed with 5% potassium bisulfate aqueous solution for 3 times, saturated brine for 2 times, dried over anhydrous sodium sulfate, and concentrated to obtain an oily substance which was directly used in the next reaction.

[0068] The oily substance from the previous step was dissolved in 100 ml of acetonitrile, and 9.16 g of DSC (2.0 eq) and 4.62 g of DIEA were added. After reacting for 5 hours, the mixture was washed with 5% potassium hydrogen sulfate aqueous solution for 3 times, saturated brine for 2 times, dried over anhydrous sodium sulfate, and concentrated to obtain an oily substance for purification.

[0069] The oily substance from the previous step was dissolved in 150 ml of THF, and the pH was adjusted to above 10 with 1 M NaOH aqueous solution. The temperature was controlled at 25±5° C. and the reaction was stirred for 3 h. The reaction progress was monitored by TLC (DCM / methanol, V / V, 10 / 1).

[0070] TLC showed that the reaction of the raw material was complete, so the reaction was terminated and the pH was adjusted to 7.0. After purification, 2.65 g of pGlu-His(Trt)-Trp(Boc)-Dha was obtained.

[0071] Preparation of fragment 2: H-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-NHC2H5

[0072] Weigh 5.0mmol AM resin, load HMBA linker, and then load Fmoc-Pro-OH, Fmoc-Leu-Arg(Pbf)-OH, Fmoc-D-Leu-OH, Fmoc-Tyr(OtBu)-OH in sequence. After coupling, Fmoc-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-HMBA is obtained. linker-AM resin; use ethylamine-THF (1:1, v / v) to deamine the resin for 24 hours, concentrate and precipitate with isopropyl ether, and vacuum dry to obtain the fully protected crude peptide Fmoc-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-NHC2H5; prepare 20% piperidine / DBU, add the solid to the solution, stir for 30 minutes, and remove Fmoc to obtain H-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-NHC2H5.

[0073] Preparation of Leuprorelin Impurity K

[0074] Dissolve fragment 2 in DMF, dissolve fragment 1 and HOBT in DMF, control the temperature at 0-5°C, slowly add to the reaction bottle, stir and react for 3 hours, monitor the reaction progress by TLC (DCM / methanol, V / V, 10 / 1), and obtain a crude product of leuprorelin impurity K. Take a small amount of the crude product for analysis, and the product is tested by analytical liquid HPLC, with a purity of 78.12% and a yield of 60.3%.

[0075] Take the crude product of leuprorelin impurity K, dissolve it with purified water, and filter it with a whatman filter membrane after it is completely dissolved. Then purify it using a reverse phase C18 packed column ZB025. 0.1% TFA / acetonitrile is used for equilibrium replacement. After the fractions are detected, they are combined and concentrated by rotary evaporation and freeze-dried to obtain leuprorelin impurity K. The product is tested by analytical liquid HPLC, and the HPLC spectrum is consistent with Figure 2 The purity is similar to that shown in Figure 1, and the purity is 99.14%. The molecular ion peak of the sample detected in the positive ion mode of the mass spectrometry electrospray ionization source is 1191.74, which is consistent with the theoretical value of the relative molecular mass of the leuprorelin impurity K, M = 1191.41. The MS spectrum is similar to that of the Figure 3 similar.

[0076] Example 4: Preparation of Leuprorelin Impurity K 2

[0077] Preparation of fragment 1: pGlu-His(Trt)-Trp(Boc)-Dha

[0078] Weigh 5.0mmol Trityl chloride resin, load Fmoc-Trp(Boc)-OH, then load Fmoc-His(Trt)-OH and pGlu-OH in sequence. After coupling, pGlu-His(Trt)-Trp(Boc)-CTC resin is obtained, and 20% TFE is used for cleavage to obtain the fully protected tripeptide pGlu-His(Trt)-Trp(Boc)-OH.

[0079] 14.20 g of the fully protected tripeptide and 3.62 g of HOPFP (1.3 eq) were dissolved in 200 ml of DCM and stirred to clarify. 4.46 g of EDCI (1.3 eq) was added and reacted for 1 h. 8.09 g of DIEA and 5.57 g of H-Ser.OMe.HCl were added and reacted for 4 hours. The mixture was washed 3 times with 5% potassium bisulfate aqueous solution and 2 times with saturated brine, dried over anhydrous sodium sulfate, and concentrated to obtain an oily substance which was directly used in the next reaction.

[0080] The oily substance from the previous step was dissolved in 100 ml of acetonitrile, and 9.16 g of DSC (2.0 eq) and 4.62 g of DIEA were added. After reacting for 5 hours, the mixture was washed with 5% potassium hydrogen sulfate aqueous solution for 3 times, saturated brine for 2 times, dried over anhydrous sodium sulfate, and concentrated to obtain an oily substance for purification.

[0081] The oily substance from the previous step was dissolved in 150 ml of THF, and the pH was adjusted to above 10 with 1 M NaOH aqueous solution. The temperature was controlled at 25±5° C. and the reaction was stirred for 3 h. The reaction progress was monitored by TLC (DCM / methanol, V / V, 10 / 1).

[0082] TLC showed that the reaction of the raw material was complete, so the reaction was terminated and the pH was adjusted to 7.0. After purification, 2.61 g of pGlu-His(Trt)-Trp(Boc)-Dha was obtained.

[0083] Preparation of fragment 2: H-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-NHC2H5

[0084] Weigh 5.0mmol AM resin, load HMBA linker, and then load Fmoc-Pro-OH, Fmoc-Leu-Arg(Pbf)-OH, Fmoc-D-Leu-OH, Fmoc-Tyr(OtBu)-OH in sequence. After coupling, Fmoc-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-HMBA is obtained. linker-AM resin; use ethylamine-THF (3:7, v / v) to deamine the resin for 24 hours, concentrate and precipitate with isopropyl ether, and vacuum dry to obtain the fully protected crude peptide Fmoc-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-NHC2H5; prepare 20% piperidine / DBU, add the solid to the solution, stir for 30 minutes, and remove Fmoc to obtain H-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-NHC2H5.

[0085] Preparation of Leuprorelin Impurity K

[0086] Dissolve fragment 2 in DMF, dissolve fragment 1 and HOBT in DMF, control the temperature at 0-5°C, slowly add to the reaction bottle, stir and react for 3 hours, monitor the reaction progress by TLC (DCM / methanol, V / V, 10 / 1), and obtain a crude product of leuprorelin impurity K. Take a small amount of the crude product for analysis, and the product is tested by analytical liquid HPLC, with a purity of 78.12% and a yield of 60.3%.

[0087] Take the crude product of leuprorelin impurity K, dissolve it with purified water, and filter it with a whatman filter membrane after it is completely dissolved. Then purify it using a reverse phase C18 packed column ZB025. 0.1% TFA / acetonitrile is used for equilibrium replacement. After the fractions are detected, they are combined and concentrated by rotary evaporation and freeze-dried to obtain leuprorelin impurity K. The product is tested by analytical liquid HPLC, and the HPLC spectrum is consistent with Figure 2 The purity is similar to that shown in Figure 1, and the purity is 99.12%. The molecular ion peak of the sample detected in the positive ion mode of the mass spectrometry electrospray ionization source is 1191.74, which is consistent with the theoretical value of the relative molecular mass of the leuprorelin impurity K, M = 1191.41. The MS spectrum is similar to that of the Figure 3 similar.

[0088] Example 5: Preparation of Leuprorelin Impurity K 2

[0089] Preparation of fragment 1: pGlu-His(Trt)-Trp(Boc)-Dha

[0090] Weigh 5.0mmol Trityl chloride resin to load Fmoc-Trp(Boc)-OH, then load Fmoc-His(Trt)-OH and pGlu-OH in sequence. After coupling, pGlu-His(Trt)-Trp(Boc)-CTC resin is obtained, and 20% TFE is used for cleavage to obtain the fully protected tripeptide pGlu-His(Trt)-Trp(Boc)-OH.

[0091] 14.20 g of the fully protected tripeptide and 3.62 g of HOSU (1.3 eq) were dissolved in 200 ml of DCM and stirred to clarify. 4.46 g of EDCI (1.3 eq) was added and reacted for 1 h. 8.09 g of DIEA and 5.56 g of H-Ser.OMe.HCl were added and reacted for 4 hours. The mixture was washed 3 times with 5% potassium bisulfate aqueous solution and 2 times with saturated brine, dried over anhydrous sodium sulfate, and concentrated to obtain an oily substance which was directly used in the next reaction.

[0092] The oily substance from the previous step was dissolved in 100 ml of acetonitrile, and 9.16 g of DSC (2.0 eq) and 4.62 g of DIEA were added. After reacting for 5 hours, the mixture was washed with 5% potassium hydrogen sulfate aqueous solution for 3 times, saturated brine for 2 times, dried over anhydrous sodium sulfate, and concentrated to obtain an oily substance for purification.

[0093] The oily substance from the previous step was dissolved in 150 ml of THF, and the pH was adjusted to above 10 with 1 M NaOH aqueous solution. The temperature was controlled at 25±5° C. and the reaction was stirred for 3 h. The reaction progress was monitored by TLC (DCM / methanol, V / V, 10 / 1).

[0094] TLC showed that the reaction of the raw material was complete, so the reaction was terminated and the pH was adjusted to 7.0. After purification, 2.558 g of pGlu-His(Trt)-Trp(Boc)-Dha was obtained.

[0095] Preparation of fragment 2: H-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-NHC2H5

[0096] Weigh 5.0 mmol AM resin, load HMBAlinker, and then load Fmoc-Pro-OH, Fmoc-Leu-Arg(Pbf)-OH, Fmoc-D-Leu-OH, and Fmoc-Tyr(OtBu)-OH in sequence. After the coupling, Fmoc-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-HMBAlinker-AM resin was obtained. Use ethylamine-THF( 1:1, v / v) was used to deamine the resin for 24 h, and after concentration, isopropyl ether was precipitated and vacuum-dried to obtain the fully protected crude peptide Fmoc-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-NHC2H5; 20% piperidine / DBU was prepared, and the solid was added to the solution, stirred for 30 min, and H-Tyr(OtBu)-D-Leu-Leu-Arg(Pbf)-Pro-NHC2H5 was obtained after Fmoc removal.

[0097] Preparation of Leuprorelin Impurity K

[0098] Dissolve fragment 2 in DMF, dissolve fragment 1 and HOBT in DMF, control the temperature at 0-5°C, slowly add to the reaction bottle, stir and react for 3 hours, monitor the reaction progress by TLC (DCM / methanol, V / V, 10 / 1), and obtain a crude product of leuprorelin impurity K. Take a small amount of the crude product for analysis, and the product is tested by analytical liquid HPLC, with a purity of 78.13% and a yield of 60.5%.

[0099] Take the crude product of leuprorelin impurity K, dissolve it with purified water, and filter it with a what man filter membrane after it is completely dissolved. Then purify it using a reverse phase C18 packed column ZB025. 0.1% TFA / acetonitrile is used for equilibrium replacement. After the fractions are detected, they are combined and concentrated by rotary evaporation and freeze-dried to obtain leuprorelin impurity K. The product is tested by analytical liquid HPLC, and the HPLC spectrum is consistent with Figure 2 The purity is similar to that shown in Figure 1, and the purity is 99.14%. The molecular ion peak of the sample detected in the positive ion mode of the mass spectrometry electrospray ionization source is 1191.74, which is consistent with the theoretical value of the relative molecular mass of the leuprorelin impurity K, M = 1191.41. The MS spectrum is similar to that of the Figure 3 similar.

Claims

1. A method for preparing leuprorelin impurity K, characterized in that: The main steps include: Step 1, synthesis of fragment 1: pGlu-His(R1)-Trp(R2)-Dha; Step 2, synthesis of fragment 2: H-Tyr(R3)-D-Leu-Leu-Arg(R4)-Pro-NHC2H5; Step 3, coupling fragments 1 and 2 to obtain fully protected fragment 3: pGlu-His(R1)-Trp(R2)-Dha-Tyr(R3)-D-Leu-Leu-Arg(R4)-Pro-NHC2H5; Step 4, fragment 3 is cleaved to obtain leuprorelin impurity K; Wherein, R1 is hydrogen or an amino protecting group, R2 is hydrogen or an amino protecting group, R3 is hydrogen or a hydroxyl protecting group, R4 is hydrogen or an amino protecting group.

2. The preparation method according to claim 1, characterized in that: The R1 is selected from Trt, Boc, and Mtt.

3. The preparation method according to claim 1, characterized in that: The R2 is selected from Boc.

4. The preparation method according to claim 1, characterized in that: The R3 is selected from OtBu.

5. The preparation method according to claim 1, characterized in that: The R4 is selected from H, pbf, and Mts.

6. The preparation method according to claim 1, characterized in that: The preparation method of fragment 1 is:

7. The preparation method according to claim 6, characterized in that: The preparation method of pGlu-His(R1)-Trp(R2)-Ser-OMe is as follows: take a resin, load Fmoc-Trp(R2)-OH, sequentially load Fmoc-His(R1)-OH, pGlu-OH, obtain pGlu-His(R1)-Trp(R2)-resin after coupling, obtain pGlu-His(R1)-Trp(R2)-resin after cleavage, and then react with H-Ser.OMe.HCl, wash, dry, and concentrate to obtain pGlu-His(R1)-Trp(R2)-Ser-OMe.

8. The preparation method according to claim 7, characterized in that: The resin is CTC resin or Tritylchlorideresin.

9. The preparation method according to claim 7, characterized in that: The cleavage was performed using 20% ​​TFE.

10. The preparation method according to claim 1, characterized in that: The preparation method of fragment 2 is as follows: take resin, load linker, and then sequentially load Fmoc-Pro-OH, Fmoc-Leu-Arg(R4)-OH, Fmoc-D-Leu-OH, and Fmoc-Tyr(R3)-OH. After coupling, perform aminolysis and remove Fmoc to obtain H-Tyr(R3)-D-Leu-Leu-Arg(R4)-Pro-NHC2H5.

11. The preparation method according to claim 10, characterized in that: The resin is AM resin.

12. The preparation method according to claim 10, characterized in that: The linker is an HMBA linker.

13. The preparation method according to claim 10, characterized in that: The reagent used in the aminolysis is ethylamine: THF=3:7~1:

1.

14. The preparation method according to claim 10, characterized in that: The reagent used for removing Fmoc is: 50% diethylamine / DCM.